Prescription Drugs: Cost Effectiveness
The question
To ask the Secretary of State for Health and Social Care, when his Department plans to release an impact assessment for changes to the NICE cost-effectiveness threshold.
Answered by Dr Zubir Ahmed
There are no plans to publish an impact assessment or details of the modelling in relation to changes to the National Institute for Health and Care Excellence cost-effectiveness threshold. Information included in the impact assessment is commercially sensitive.
The United Kingdom and United States’ pharmaceutical deal is a vital investment that builds on the strength of our National Health Service and world leading life sciences sector.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →